WellGen Raises $3M in Series B Financing | GenomeWeb

NEW YORK, Feb. 16 (GenomeWeb News) - WellGen closed a $3-million Series B funding round, the company said today.

 

The capital will be used to begin clinical studies in humans under its obesity and inflammation programs, said the company in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.